Home » Topics » BioWorld Science

BioWorld Science
RSS

Sanofi reports updates for Dupixent as treatment in adolescents and children with atopic dermatitis

Aug. 6, 2019

Pivotal IMPALA study of lefitolimod in colorectal cancer misses primary endpoint

Aug. 6, 2019

Eloxx Pharmaceuticals initiates phase II study for ELX-02 in cystinosis

Aug. 6, 2019

Small molecule WX2-43 targets PRMT5-KLF4 for triple-negative breast cancer treatment

Aug. 6, 2019

Derivatives of Nectandra leucantha neolignans with activity against Trypanosoma cruzi

Aug. 6, 2019

Researchers report findings on distribution studies of ENV-101

Aug. 6, 2019

Adenosine A2A receptor antagonists disclosed by Sichuan Kelun-Biotech Biopharmaceutical

Aug. 6, 2019

Nanjing TransThera Biosciences discloses TRYO3/ AXL/MERTK/CSF-1R inhibitors

Aug. 6, 2019

Vertex Pharmaceuticals patents DNA-dependent protein kinase inhibitors

Aug. 6, 2019

Influenza cap-dependent endonuclease inhibitors described by Ginkgo Pharmaceutical

Aug. 6, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...